Skip to main content
. 2018 Apr 10;9(27):19396–19405. doi: 10.18632/oncotarget.25036

Figure 3. Trends in weighted MOS.

Figure 3

Drug regimens are listed in order of publication in large phase three clinical trials [1, 11, 28, 29].